|
|
 |
|
Viewing report
|
|
|
Biomarin Pharmaceutical Inc (22-Nov-2010)
Directors Deals Ltd, Nov 2010, Pages: 1
Steve Aselage, (PDMR) of Biomarin Pharmaceutical Inc [market cap £1614million] sold after exercising options/sold 39,875 shares at 25.753USD, holding is now 59,762 shares; representing 0.058 percent of the shares on issue. Holding has decreased 21 percent, the total trade value was £647,321 and the significance rating is 56/100.
Directors Deals monitors and analyses share transactions made by directors in the shares of their own company. We monitor 18,000 companies share transactions in 46 countries worldwide (32 in Europe, 7 in Asia, 2 in North America, 2 in Oceania, 2 in the Middle East & 2 in Africa).
|
|
|
|
